Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,512 results
- Trial Of NS2359 For The Treatment of Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Trial Of NS2359 For The Treatment of Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02798627).
- Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II): Complete Statistical AnalysisIndependent statistical analysis of Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553254).
- Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain: Complete Statistical AnalysisIndependent statistical analysis of Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03407430).
- Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients: Complete Statistical AnalysisIndependent statistical analysis of Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Trial of RAD001 in Triple Negative Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of RAD001 in Triple Negative Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00827567).
- Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy: Complete Statistical AnalysisIndependent statistical analysis of Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02579161).
- Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age: primary endpoint…
- Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers: Complete Statistical AnalysisIndependent statistical analysis of Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers: primary endpoint results, effect estimate with confidence interval, sample-size…
- Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India: Complete Statistical AnalysisIndependent statistical analysis of Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183): Complete Statistical AnalysisIndependent statistical analysis of Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates: Complete Statistical AnalysisIndependent statistical analysis of Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Trial to Evaluate CIS43LS in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Trial to Evaluate CIS43LS in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04206332).
- Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients: Complete Statistical AnalysisIndependent statistical analysis of Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients: primary endpoint results, effect estimate with confidence interval,…
- Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals’ Influenza Vaccine GSK2186877A in Healthy Children: Complete Statistical AnalysisIndependent statistical analysis of Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women: primary endpoint results, effect…
- Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02541903).
- Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles: Complete Statistical AnalysisIndependent statistical analysis of Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC): Complete Statistical AnalysisIndependent statistical analysis of Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC): primary endpoint results, effect estimate with confidence interval,…
- Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00350142).
- TRIMIndependent statistical analysis of Trial of Roflumilast in Asthma Management (TRIM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03532490).
- trinkfitIndependent statistical analysis of Promoting Water Consumption for Prevention of Overweight in School Children in a Controlled Intervention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TRITON3Independent statistical analysis of A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency: primary endpoint results, effect estimate with confidence…
- TRIUMPHIndependent statistical analysis of Treatment of Incontinence Without Memory Problems: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02436889).
- Trospium Chloride XR in Obese Female Patients With Overactive Bladder: Complete Statistical AnalysisIndependent statistical analysis of Trospium Chloride XR in Obese Female Patients With Overactive Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00932022).
- TROYAIndependent statistical analysis of Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment: primary endpoint results, effect…
- TRUSTIndependent statistical analysis of Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02917265).
- tSCI Contrast Enhanced Ultrasound Study: Complete Statistical AnalysisIndependent statistical analysis of tSCI Contrast Enhanced Ultrasound Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04056988).
- TTRACKIndependent statistical analysis of Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TULIP-LN1Independent statistical analysis of Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis: primary endpoint results, effect estimate with confidence interval, sample-size…
- TURFIndependent statistical analysis of Study for Recalcitrant Age Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01543568).
- TURQUOISE-CPBIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4…
- TVEC-325Independent statistical analysis of Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Twitter-enabled Mobile Messaging for Smoking Relapse Prevention: Complete Statistical AnalysisIndependent statistical analysis of Twitter-enabled Mobile Messaging for Smoking Relapse Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01602536).
- Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation: Complete Statistical AnalysisIndependent statistical analysis of Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Two Devices for Reflex Voiding Following Spinal Cord Injury: Complete Statistical AnalysisIndependent statistical analysis of Two Devices for Reflex Voiding Following Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00662207).
- Two Dose Epidural Morphine for Post-cesarean Analgesia: Complete Statistical AnalysisIndependent statistical analysis of Two Dose Epidural Morphine for Post-cesarean Analgesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01844206).
- Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection: Complete Statistical AnalysisIndependent statistical analysis of Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®.: Complete Statistical AnalysisIndependent statistical analysis of Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TWO2DFUIndependent statistical analysis of Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TWPSIndependent statistical analysis of Long-Term Effects of Torso-Weighting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02743312).
- TX-SMILEIndependent statistical analysis of Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03682965).
- Tx-TreatmentIndependent statistical analysis of Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TXAIndependent statistical analysis of TXA Study in Major Oncologic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01980355).
- TXA vs. Amicar in Total Knee and Hip Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of TXA vs. Amicar in Total Knee and Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02030821).
- UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission: Complete Statistical AnalysisIndependent statistical analysis of UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses: Complete Statistical AnalysisIndependent statistical analysis of Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02276963).